 | • レポートコード：MRC2109A049 • 出版社/出版日：Transparency Market Research / 2021年6月29日 • レポート形態：英文、PDF、176ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、フィブリンシーラントの世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、主要インサイト、剤形別（液体、パッチ、粉末）分析、疾患別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しております。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・フィブリンシーラントの世界市場規模：剤形別（液体、パッチ、粉末） ・フィブリンシーラントの世界市場規模：疾患別 ・フィブリンシーラントの世界市場規模：エンドユーザー別 ・フィブリンシーラントの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Fibrin Sealants Market – Scope of Report
TMR’s report on the fibrin sealants market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global fibrin sealants market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global fibrin sealants market for the forecast period of 2021–2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global fibrin sealants market.
Secondary research included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global fibrin sealants market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the fibrin sealants market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the fibrin sealants market.
The report also delves into the competition landscape of the global fibrin sealants market. Key players operating in the global fibrin sealants market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the fibrin sealants market profiled in this report.
Key Questions Answered in Fibrin Sealants Market Report
How does the development of fibrin sealants provide scope of growth in the global fibrin sealants market?
How alliances and partnerships between players are widening the scope of new line of technologies for fibrin sealants?
What are the revenue share projections of key segments under various criteria in the fibrin sealants market during the forecast period?
Which segment is likely to register highest revenue by the end of the forecast period in 2031?
How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall fibrin sealants market?
Fibrin Sealants Market – Research Objectives and Research Approach
The comprehensive report on the global fibrin sealants market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for fibrin sealants.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global fibrin sealants market in terms of dosage form, indication, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global fibrin sealants market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Fibrin Sealants Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Fibrin Sealants Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)
5.3. TISSEEL Fibrin Sealant Sales and Forecast (US$ Mn) 2017-2031, by Country/Region
5.4. % Share of Marketed Fibrin Sealants by Product/Company in the Global Fibrin Sealants Market (2020)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Fibrin Sealants Market Analysis and Forecast, by Dosage Form
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Dosage Form, 2017–2031
6.3.1. Liquid
6.3.2. Patch
6.3.3. Powder
6.4. Market Attractiveness Analysis, by Dosage Form
7. Global Fibrin Sealants Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. General Surgery
7.3.2. Cardiovascular Surgery
7.3.3. Wound Management
7.3.4. Orthopedic Surgery
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Fibrin Sealants Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Fibrin Sealants Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Fibrin Sealants Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Dosage Form, 2017–2031
10.2.1. Liquid
10.2.2. Patch
10.2.3. Powder
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. General Surgery
10.3.2. Cardiovascular Surgery
10.3.3. Wound Management
10.3.4. Orthopedic Surgery
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Dosage Form
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Fibrin Sealants Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Dosage Form, 2017–2031
11.2.1. Liquid
11.2.2. Patch
11.2.3. Powder
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. General Surgery
11.3.2. Cardiovascular Surgery
11.3.3. Wound Management
11.3.4. Orthopedic Surgery
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Dosage Form
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Fibrin Sealants Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Dosage Form, 2017–2031
12.2.1. Liquid
12.2.2. Patch
12.2.3. Powder
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. General Surgery
12.3.2. Cardiovascular Surgery
12.3.3. Wound Management
12.3.4. Orthopedic Surgery
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Dosage Form
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Fibrin Sealants Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Dosage Form, 2017–2031
13.2.1. Liquid
13.2.2. Patch
13.2.3. Powder
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. General Surgery
13.3.2. Cardiovascular Surgery
13.3.3. Wound Management
13.3.4. Orthopedic Surgery
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Dosage Form
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Fibrin Sealants Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Dosage Form, 2017–2031
14.2.1. Liquid
14.2.2. Patch
14.2.3. Powder
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. General Surgery
14.3.2. Cardiovascular Surgery
14.3.3. Wound Management
14.3.4. Orthopedic Surgery
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Dosage Form
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis/Ranking, by Company, 2020
15.3. Company Profiles
15.3.1. Baxter
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. Pfizer Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. Takeda Pharmaceutical Company
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Johnson & Johnson (Ethicon, Inc.)
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Grifols, S.A.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. CSL Limited
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. Vivostat A/S
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Stryker
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Hemarus
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis
15.3.10. Asahi Kasei Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
Table 01: Key Industry Events
Table 02: ISSEEL Fibrin Sealant Sales and Forecast (US$ Mn) 2017-2031, by Region
Table 03: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 04: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 05: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 09: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 10: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 13: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 14: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 17: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 18: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 20: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 21: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 23: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 25: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 26: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031